Mycophenolate therapy of SLE membranous nephropathy
- 1 December 2004
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 66 (6) , 2411-2415
- https://doi.org/10.1111/j.1523-1755.2004.66030.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Factors affecting outcome and prognosis in membranous lupus nephropathyNephrology Dialysis Transplantation, 2002
- The safety and efficacy of MMF in lupus nephritis: a pilot study.Lupus, 2001
- Renoprotection: One or many therapies?Kidney International, 2001
- Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus NephritisNew England Journal of Medicine, 2000
- Mycophenolate Mofetil Therapy in Lupus NephritisJournal of the American Society of Nephrology, 1999
- A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1996
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995
- Comparison of Idiopathic and Systemic Lupus ErythematosusAssociated Membranous Glomerulonephropathy in ChildrenAmerican Journal of Kidney Diseases, 1986
- MEMBRANOUS LUPUS NEPHROPATHYMedicine, 1977